---
schema_version: "secwatch.filing_event.v1"
accession: "0000914475-25-000186"
form_type: "8-K"
ticker: "NBIX"
cik: "0000914475"
company_name: "NEUROCRINE BIOSCIENCES INC"
filed_at: "2025-11-24T23:59:59+00:00"
generated_at: "2026-05-16T17:30:24.349853+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Neurocrine extends former CMO Eiry Roberts as Strategic Advisor through Dec 31, 2026

## Summary
- Roberts, former CMO, transitioned to Strategic Advisor effective June 2, 2025; term extended to Dec 31, 2026 (Amended Employment Agreement).
- Base salary of $731,400 through Dec 31, 2025; future salary to be set by Compensation Committee thereafter.
- Annual cash incentive bonus target 60% of base pay for 2025 and 2026, subject to corporate and individual goals.
- Employment agreement expires Dec 31, 2026 unless earlier terminated; no severance upon natural expiration.

## SEC filing metadata
- accession: 0000914475-25-000186
- form_type: 8-K
- ticker: NBIX
- cik: 0000914475
- company_name: NEUROCRINE BIOSCIENCES INC
- filed_at: 2025-11-24T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/914475/000091447525000186/0000914475-25-000186-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/914475/000091447525000186/nbix-20251121.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000914475-25-000186
- JSON: https://secwatch.observer/filing/0000914475-25-000186.json
- Plain text: https://secwatch.observer/filing/0000914475-25-000186.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.